Cargando…
Circulating Osteoprotegerin Levels Independently Predict All-cause Mortality in Patients with Chronic Kidney Disease: a Meta-analysis
Background: Studies have shown inconsistent results regarding the association between circulating osteoprotegerin (OPG) levels and all-cause mortality in patients with chronic kidney disease (CKD). The aim of this meta-analysis is to investigate the association between circulating OPG levels and all...
Autores principales: | Huang, Qing-xiu, Li, Jian-bo, Huang, Xiao-wen, Jiang, Lan-ping, Huang, Lin, An, Hai-wen, Yang, Wen-qin, Pang, Jie, Li, Yan-lin, Huang, Feng-xian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818186/ https://www.ncbi.nlm.nih.gov/pubmed/31692972 http://dx.doi.org/10.7150/ijms.34274 |
Ejemplares similares
-
Circulating Osteoprotegerin in Chronic Kidney Disease and All-Cause Mortality
por: Kamińska, Joanna, et al.
Publicado: (2021) -
Elevated Circulating Osteoprotegerin and Renal Dysfunction Predict 15-Year Cardiovascular and All-Cause Mortality: A Prospective Study of Elderly Women
por: Lewis, Joshua R., et al.
Publicado: (2015) -
Kidney Function Change and All-Cause Mortality in Denosumab Users with and without Chronic Kidney Disease
por: Wu, Ping-Hsun, et al.
Publicado: (2022) -
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
por: Bernardi, Stella, et al.
Publicado: (2017) -
Elevated levels of plasma osteoprotegerin are associated with all-cause
mortality risk and atherosclerosis in patients with stages 3 to 5 chronic kidney
disease
por: Nascimento, M.M., et al.
Publicado: (2014)